214 related articles for article (PubMed ID: 8000111)
21. Has the use of antithyroid drugs for Graves' disease become obsolete?
Wartofsky L
Thyroid; 1993; 3(4):335-44. PubMed ID: 7509673
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
23. Airway complication occurring during radioiodine treatment for Graves' disease.
Kinuya S; Yoneyama T; Michigishi T
Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
[TBL] [Abstract][Full Text] [Related]
24. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
25. [Interaction between cigarette smoking and glucocorticoids therapy and therapeutic doses of radioiodine (131I) in patients with Graves’ disease].
Płazińska MT; Prasek K; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Borowska M; Kobylecka M; Florek E; Faryna M; Królicki L
Przegl Lek; 2016; 73(10):766-72. PubMed ID: 29689681
[TBL] [Abstract][Full Text] [Related]
26. Comparison of RA 131I treatment protocols for Graves' disease.
DeGroot LJ; Mangklabruks A; McCormick M
J Endocrinol Invest; 1990 Feb; 13(2):111-8. PubMed ID: 2329258
[TBL] [Abstract][Full Text] [Related]
27. Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
Yu J; Tian AJ; Yuan X; Cheng XX
PLoS One; 2016; 11(5):e0154846. PubMed ID: 27135245
[TBL] [Abstract][Full Text] [Related]
28. Pterional orbital decompression in progressive ophthalmopathy of Graves' disease. I. Short-term effects.
Algvere P; Almqvist S; Backlund EO
Acta Ophthalmol (Copenh); 1973; 51(4):461-74. PubMed ID: 4128795
[No Abstract] [Full Text] [Related]
29. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
30. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
31. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
32. [Therapy for Graves' ophthalmopathy].
Zheng J; Zhang X; Gong R; Wang J; Tan T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Graves' disease and the course of ophthalmopathy.
Sridama V; DeGroot LJ
Am J Med; 1989 Jul; 87(1):70-3. PubMed ID: 2741983
[TBL] [Abstract][Full Text] [Related]
35. Radioiodine and aggravation of Graves' ophthalmopathy.
Vestergaard H; Laurberg P
Lancet; 1989 Jul; 2(8653):47. PubMed ID: 2567820
[No Abstract] [Full Text] [Related]
36. [Ablative therapy for immune hyperthyroidism in patients with ophthalmopathy].
Lind P
Acta Med Austriaca; 2001; 28(4):105-7. PubMed ID: 11593892
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
38. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
[TBL] [Abstract][Full Text] [Related]
39. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
Wartofsky L
Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
[TBL] [Abstract][Full Text] [Related]
40. Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter.
Nygaard B; Metcalfe RA; Phipps J; Weetman AP; Hegedüs L
J Endocrinol Invest; 1999 Jun; 22(6):481-5. PubMed ID: 10435860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
